Research Facilities and Equipment for Research in the Field of Medical Sciences

DATA ABOUT RESPONDENT

Full name
Mr Pavle Milenković
Name of your institution
Institute for Medical Research
Institutions’s country
Serbia
Institution’s address
Dr Subotica 4, POBox 102, 11129 Belgrade, Serbia
Are you responsible on behalf of the institution
Yes
Your position in the institution
  • Other: Head of Experimental hematology
Your telephone number
+381 11 685788
Your email address
mpavle@imi.bg.rs
Institution's website address
http://www.imi.bg.ac.rs/

GENERAL INFORMATION ABOUT RESEARCH INFRASTRUCTURE OR IMPORTANT RESEARCH EQUIPMENT

Research infrastrcture website
http://www.imi.bg.ac.rs/
Organisation / institution type of RI
  • National scientific organisation/institution

Main scientificdomain: Life sciences

Category: Clinical research centers

Other scientific and technological domains served by RI
  • Life Sciences
RI type
  • Single-sited
Short description

Institute for medical research has been operating for more than two and a half decades. It is a public research institution, supported mostly by public partnership. It is already coordinating an INCO FP6 project, thus having established collaboration with centres of excellence or laboratories. Its research infrastructure is open towards external users, namely medical, biomedical and university institutions as well as other interested parties.

OPERATION AND UPGRADE OF RESEARCH INFRASTRUCTURE AND OR IMPORTANT RESEARCH EQUIPMENT

Years in operation
  • 21 – 25 years
Comment on cooperation
There are no differences in access policy for different groups (e.g. researchers from EU Member states, researchers from other Western Balkan Countries, researchers from industrialised countries such as US, Canada, Japan and researchers from other countries). Also, there are no specific requirements or limitations for researchers from WBC and third countries when coming to the institution, only when they are to be employed by the institutions, the general national requirements are to be met. There is no clearly defined strategic approach or policy to attract researchers from EU member states or from other countries. Currently, France is identified as main cooperation partner, and the willingness and openness to all kinds of cooperation with all EU and other countries is clearly stated. As main possible ways for carrying out the international cooperation, the institution mentions possible bilateral projects and joint FP7 applications. In addition, the existing bilateral cooperation with partner in France, through a project \"Pavle Savic\" under FP6 INCO, as well as SSA project FP7 in preparation is described. As an example of a success story, coordinating the mentioned FP6 project is introduced, with general comment that the main difficulty in cooperation both, within the FP and with EU countries is complexity of administrative procedures.

STAFF, INTERNAL USERS AND EXTERNAL USERS

FINANCE

Main sources of funding for setting up RI or important equipment
  • National public funding
  • Multinational/international public funding
Main sources of funding for operational costs
  • National public funding
  • Multinational/international public funding

SCIENTIFIC IMPACT

RESEARCH SERVICES PROVIDED TO USERS AND RESEARCHERS

Research services provided to users and researchers
np

Entry created by Elke Dall on February 17, 2010
Modified on October 24, 2012